CRVO insider transaction filings
CervoMed Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen CRVO transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for CRVO between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — CervoMed Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-15 | 4 | BOGER JOSHUA S — Director, 10% owner | Purchase (P): 955,414 @ $3.14 · Purchase (P): 955,414 (derivative) · Purchase (P): 955,414 (derivative) | EDGAR |
| 2026-06-10 | 4 | ZAVRL FRANK — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Sabbagh Marwan — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Quigley David — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | BOGER JOSHUA S — Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 8,150 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Winton Matthew — Chief Commercial and Business | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | De Rosch Mark — EVP, RA and GA and PgM | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Blackburn Kelly — EVP, Clinical Development | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Quigley David — Director | Grant/award (A): 16,200 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Winton Matthew — Chief Commercial and Business | Purchase (P): 3,500 @ $8.43 · Purchase (P): 1,500 @ $7.95 | EDGAR |
| 2025-11-19 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 10,793 @ $8.46 · Purchase (P): 10,807 @ $8.46 | EDGAR |
| 2025-11-19 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 1,000 @ $8.45 · Purchase (P): 2,500 @ $8.32 | EDGAR |
| 2025-11-19 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 10,807 @ $8.46 · Purchase (P): 10,793 @ $8.46 | EDGAR |
| 2025-11-17 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 4,447 @ $7.51 · Purchase (P): 1,707 @ $7.57 · Purchase (P): 1,693 @ $7.55 | EDGAR |
| 2025-11-17 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 4,447 @ $7.51 · Purchase (P): 1,693 @ $7.55 · Purchase (P): 1,707 @ $7.57 | EDGAR |
| 2025-11-17 | 4 | Winton Matthew — Chief Commercial and Business | Purchase (P): 10,000 @ $7.57 | EDGAR |
| 2025-11-13 | 4 | Gregoire Sylvie — Director, 10% owner | Purchase (P): 5,553 @ $7.35 | EDGAR |
| 2025-11-13 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 3,500 @ $7.44 | EDGAR |
| 2025-11-13 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Purchase (P): 5,553 @ $7.35 | EDGAR |
| 2025-10-08 | 4 | Winton Matthew — Chief Commercial and Business | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | ZAVRL FRANK — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | BOGER JOSHUA S — Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Sabbagh Marwan — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 8,100 (derivative) @ $0 | EDGAR |
| 2025-05-14 | 4 | ELDER WILLIAM ROBERT — CFO, GC & Secretary | Purchase (P): 4,233 @ $8.46 | EDGAR |
| 2025-02-14 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ELDER WILLIAM ROBERT — CFO & GC | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Cobuzzi Robert Joseph Jr. — Chief Operating Officer | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Blackburn Kelly — SVP, Clinical Development | Grant/award (A): 27,000 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | ELDER WILLIAM ROBERT — CFO & GC | Purchase (P): 1,000 @ $18.16 | EDGAR |
| 2024-06-14 | 4 | ALAM JOHN J — CEO & President, Director, 10% owner | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | BOGER JOSHUA S — Director, 10% owner | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Gregoire Sylvie — Director, 10% owner | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Hollingsworth Jane H — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Poulton Jeffrey V. — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Sabbagh Marwan — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | ZAVRL FRANK — Director | Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-02-28 | 4 | BOGER JOSHUA S — Director, 10% owner | Option exercise/expiry (X): 495,995 · Sale (S): 36 · Option exercise/expiry (X): 495,995 (derivative) | EDGAR |
| 2024-02-13 | 4 | BOGER JOSHUA S — Director | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CervoMed Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-14 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-22 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CRVO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →